ANNUAL GENERAL MEETING: 2015

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed. A summary of proxy votes is shown in the table attached, click here. Please also refer to the ‘Notice of the 2015 Annual General Meeting’ in the Report & Accounts – 31 December 2014 on page 55, click here.